title: Splenectomy status of the patient may have impact on response to donor lymphocyte infusions.
authors.forename: D
authors.initials: D
authors.lastname: Uckan-Cetinkaya
authors.forename: S
authors.initials: S
authors.lastname: Unal
authors.forename: M
authors.initials: M
authors.lastname: Cetin
authors.forename: U
authors.initials: U
authors.lastname: Sarikabadayi
authors.forename: D
authors.initials: D
authors.lastname: Aktaş
authors.forename: Y
authors.initials: Y
authors.lastname: Koç
mesh_terms: D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D012008:Recurrence; D013156:Splenectomy